|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 315.25 CHF | +1.40% |
|
+2.01% | +23.37% |
| 02:03am | ROCHE HOLDINGS AG : JP Morgan Upgrades to Neutral | ZD |
| 01:20am | Swiss stocks - Factors to watch on December 8 | RE |
Company Valuation: Roche Holding AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 264,244 | 306,810 | 239,812 | 197,073 | 205,191 | 266,083 | - | - |
| Change | - | 16.11% | -21.84% | -17.82% | 4.12% | 29.68% | - | - |
| Enterprise Value (EV) 1 | 266,126 | 324,977 | 255,396 | 215,772 | 222,528 | 279,373 | 274,237 | 266,381 |
| Change | - | 22.11% | -21.41% | -15.51% | 3.13% | 25.55% | -1.84% | -2.86% |
| P/E ratio | 18.7x | 23.4x | 18.9x | 17.1x | 24.8x | 18x | 16.5x | 15.4x |
| PBR | 7.27x | 13.2x | 8.29x | 5.91x | 5.67x | 6.44x | 5.39x | 4.62x |
| PEG | - | -12.08x | -3.69x | -2.48x | -0.9x | 0.3x | 1.72x | 2.34x |
| Capitalization / Revenue | 4.53x | 4.89x | 3.79x | 3.36x | 3.39x | 4.32x | 4.21x | 4.09x |
| EV / Revenue | 4.56x | 5.17x | 4.04x | 3.67x | 3.68x | 4.54x | 4.34x | 4.1x |
| EV / EBITDA | 11x | 13.2x | 10.2x | 9.82x | 9.45x | 11.4x | 10.7x | 10x |
| EV / EBIT | 12.4x | 14.8x | 11.5x | 11.2x | 10.7x | 12.9x | 12.2x | 11.3x |
| EV / FCF | 24.3x | 20.7x | 19.6x | 19.1x | 14.5x | 19.2x | 16.7x | 15.6x |
| FCF Yield | 4.11% | 4.83% | 5.11% | 5.23% | 6.89% | 5.22% | 5.98% | 6.39% |
| Dividend per Share 2 | 9.1 | 9.3 | 9.5 | 9.6 | 9.7 | 9.879 | 10.07 | 10.32 |
| Rate of return | 2.94% | 2.45% | 3.27% | 3.93% | 3.8% | 3.18% | 3.24% | 3.32% |
| EPS 2 | 16.52 | 16.2 | 15.37 | 14.31 | 10.31 | 17.24 | 18.89 | 20.14 |
| Distribution rate | 55.1% | 57.4% | 61.8% | 67.1% | 94.1% | 57.3% | 53.3% | 51.2% |
| Net sales 1 | 58,323 | 62,801 | 63,281 | 58,716 | 60,495 | 61,585 | 63,132 | 64,989 |
| EBITDA 1 | 24,281 | 24,692 | 25,015 | 21,976 | 23,538 | 24,576 | 25,610 | 26,550 |
| EBIT 1 | 21,536 | 21,897 | 22,173 | 19,240 | 20,823 | 21,664 | 22,519 | 23,515 |
| Net income 1 | 14,295 | 13,930 | 12,421 | 11,498 | 8,277 | 13,133 | 14,548 | 15,502 |
| Net Debt 1 | 1,882 | 18,167 | 15,584 | 18,699 | 17,337 | 13,290 | 8,154 | 298.2 |
| Reference price 2 | 309.00 | 379.10 | 290.50 | 244.50 | 255.50 | 310.90 | 310.90 | 310.90 |
| Nbr of stocks (in thousands) | 854,642 | 800,952 | 800,579 | 798,652 | 796,789 | 850,317 | - | - |
| Announcement Date | 2/4/21 | 2/3/22 | 2/2/23 | 2/1/24 | 1/30/25 | - | - | - |
1CHF in Million2CHF
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.03x | 4.54x | 11.37x | 3.18% | 330B | |
| 44.17x | 14.63x | 32.47x | 0.59% | 905B | |
| 19.27x | 5.41x | 14.97x | 2.56% | 487B | |
| 52.81x | 7.48x | 17.71x | 2.89% | 400B | |
| 27.29x | 5.16x | 15.31x | 1.78% | 281B | |
| 18.36x | 4.97x | 11.67x | 3.07% | 255B | |
| 12.89x | 4.21x | 9x | 3.24% | 248B | |
| 13.42x | 4.8x | 9.94x | 3.76% | 214B | |
| 25.21x | 6.12x | 10.51x | 2.9% | 178B | |
| 17.68x | 5.58x | 10.21x | 2.73% | 150B | |
| Average | 24.91x | 6.29x | 14.32x | 2.67% | 344.69B | |
| Weighted average by Cap. | 29.57x | 7.85x | 18.14x | 2.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ROG Stock
- Valuation Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
